KRT126P

Across TCGA pan-cancer cohorts, KRT126P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of KRT126P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where KRT126P RNA is repressed in tumor relative to normal tissue. In most cancer types KRT126P is over-expressed in tumor, although a few such as HNSC show the opposite, repressed pattern.

HNSC and LUSC are the cancer types where KRT126P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KRT126P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Female	All	−0.059	.017	3	view →
LUSC	All	All	+0.014	.007	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

KRT126P–HNSC

Open the HNSC breakdown →